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Abstract 
Poor dietary habits lead to the emergence of chronic diseases such as coronary heart disease, stroke, 
hypertension, diabetes mellitus, dyslipidemia, cancer, dementia, obesity and oxidative stress involved 
through the aggression of cells by free radicals, Knowing that these diseases cause a global burden both 
individually and economically, Several studies focus on the relationship between diet and chronic disease. 
Studies suggest that the Mediterranean diet, (MD) traditional eating habits and lifestyle specific to the 
Mediterranean region, reduce the incidence of chronic diseases and improve longevity. The MD is known 
to be one of the healthiest diets, this diet is based on herbs, spices, vegetables, fruits, olive oils, cereals 
(preferably whole grains), legumes and nuts, fish and shellfish, white meat, so the main source of dietary 
fat from MD is olive oil. Moderate consumption of eggs and dairy products, and reduced consumption of 
red meats, processed meats and foods rich in sugars and fats. MD has a beneficial fatty acid profile with a 
higher content of monounsaturated fatty acids (MSFA) and a higher MSFA / saturated fatty acid (SFA) 
ratio than non-Mediterranean diets. High consumption of dietary fiber. a low glycemic index, anti-
inflammatory effects, and antioxidant compounds, can work together to produce favorable effects on health 
status. MD is rich in vitamins and minerals, such as: vitamin B (B1, B2, niacin, B6, folate and B12) and 
antioxidant vitamins (vitamins E and C), and polyphenol, flavonoids, phytosterols, n-fatty acids 3 (alpha 
linoleic acid), resveratrol, quercetin, oleic acid, carotenoids and lutein. The purpose of this review is to 
provide an update on the current state of science regarding the relationship between the traditional 
Mediterranean diet and lifestyle related chronic diseases, and discuss the mechanisms involved and 
opportunities. In this area of research, to clarify and increase the confidence of the role of nutrition in the 
etiology of chronic diseases. 
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Diabetes mellitus, Blood pressure, Cancer, Neurodegenerative disease, Dementia and Obesity 
I. Introduction 
 Currently, more than one in three adults (about 
92.1 million) with at least one type of cardiovascular 
disease in the USA. [1], and cardiovascular disease 
(CVD) kills an estimated 17.7 million people each 
year, or 31% of all deaths worldwide [2]. WHO 
predicts that diabetes will be the seventh leading 
cause of death in 2030 [3] [4]. The type 2 diabetes 
pandemic is a huge public health problem, with 380 
million cases worldwide by 2025 [5] [6] The number 
of people with diabetes rose from 108 million in 
1980 to 422 million in 2014 [7]. The global 
prevalence of diabetes among adults over 18 has 
increased from 4.7% in 1980 to 8.5% in 2014 [7]. In 
2015, 1.6 million deaths from diabetes [7], drug 
therapy often fails over time [8], and some drugs 
have cardiovascular risks [9] [10] a major cause of 
blindness, insufficiency kidney, heart attack, stroke 
and lower limb amputation [11]. 
About 47 million people have dementia and 
there are nearly 10 million new cases each year. 
http://dx.doi.org/10.21839/jaar.2017.v2i6.122 
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[12] evidence suggesting that more than 115 
million people will be affected by 2050 [13]. 
Dementia is a syndrome characterized by 
progressive global deterioration of cognitive 
abilities in multiple domains: memory, learning, 
orientation, behavior, language, comprehension 
and judgment, and ability to perform daily 
activities. Although there are several types of 
dementia, the most common is Alzheimer's disease 
(AD) [14] [15] [16] Dementia is one of the leading 
causes of disability and dependence worldwide. 
Dementia has a physical, psychological, economic 
and social impact on caregivers, families and 
society [17]. The burden of dementia, both from 
the disease itself and financially, is great on 
individuals, families, and public health services, 
and the efficacy of current pharmacological 
treatments is inconsistent [27] [28]. High 
cholesterol increases the risk of heart disease and 
stroke. Overall, one third of ischemic heart disease 
is attributable to high cholesterol levels. The rise 
in total cholesterol is a major cause of the burden 
of disease in developed and developing countries, 
as a risk factor for ischemic heart disease and 
stroke. In Ireland, a 30% reduction in the death 
rate from heart disease was attributed to a 4.6% 
reduction in the average population for total 
cholesterol. In Finland, 50% of the decline in 
mortality from ischemic heart disease has been 
explained by the reduction of blood cholesterol 
levels in the population [18]. 
Obesity, a chronic disorder whose prevalence 
is increasing in adults, adolescents and children, is 
now considered a global epidemic and a real 
problem for health facilities [19] [20]. In many 
populations, the prevalence of overweight and 
obesity has increased rapidly over the last 20 
years. In the United States, more than 35% of 
adults and nearly 17% of young people were 
classified obese in 2009-2010 [21] and the risk of 
being overweight or obese was estimated at 50% 
and 25% respectively [22]. high health costs 
worldwide [23] Global obesity has almost tripled 
since 1975. In 2016, over 1.9 billion adults aged 
18 and over were overweight. Of these, more than 
650 million were obese.39% of adults 18 years 
and older were overweight in 2016 and 13% were 
obese. The majority of the world's population lives 
in countries where overweight and obesity kill 
more people than underweight. [24]. The global 
burden of cancer will double over the next two 
decades, [25] raising the prospect of a huge public 
health problem and, consequently, medical care. 
[25] [26]. The mortality attributed to chronic 
diseases is increasing especially among the elderly 
population. In parallel with bad eating habits, in 
addition that the population adopts more sedentary 
lifestyles. All of these factors contributed to the 
increase in chronic noncommunicable diseases 
[57]. Over the past three decades, various dietary 
strategies have been developed to promote dietary 
fitness and reduce the burden of chronic disease. 
Compared to Western eating habits,MDfavors 
local and seasonal food production to a greater 
extent. The studies have helped to find the link 
between MD and the risk reduction of chronic 
diseases such as cancer, cardiovascular disease, 
diabetes, dyslipidemia and neurodegenerative 
diseases [57].  
I-1. Objectives of the review 
This review highlights some of the 
opportunities and challenges for adopting a 
traditional Mediterranean diet, and serves to 
provide an update on the current state of science 
regarding the relationship between the traditional 
Mediterranean diet and lifestyle in relation to 
chronic diseases, and discuss the mechanisms 
involved and opportunities in this area of research, 
to clarify and increase confidence in the role of 
nutrition in the etiology of chronic diseases, and 
thus promote aging in good health. 
II. Materials and methods 
II-1. Strategy of research 
This review is based on bibliographic research 
that has been done on various databases and search 
engines: PubMed, Sciencedirect, Google Scholar, 
Cochrane Library, ClinicalTrials.gov and 
Psychinfo. The research was reduced to studies 
published in English, additional publications were 
identified from the references of the articles 
searched, and those published studies from 
January 1, 2008 to October 23, 2017, and which 
focused on Mediterranean diet and its relationship 
to the prevention and treatment of chronic 
diseases, such as: cardiovascular diseases, 
dyslipidemia, diabetes mellitus, hypertension, 
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obesity and oxidative stress and neurodegenerative 
diseases. Epidemiological and clinical studies 
were included. The main search terms with various 
combinations were used: "Mediterranean Diet", 
"Micronutrients", "Macronutrients", "Lifestyle", 
"Chronic Diseases", "Diabetes Mellitus", "Glucose 
Intolerance", "Prevention" »,« Treatment »,« 
Blood pressure »,« Dyslipidemia »,« 
Cardiovascular diseases »,« Oxidative stress »,« 
Neurodegenerative diseases »,« Dementia »,« 
Hypertension »,« Metabolic syndrome »,« Obesity 
»,« Clinical trials »,« Cohort »,« Cases / Witnesses 
». There were 53 studies after the exclusion of 
duplicate studies (7 studies) and the exclusion of 
studies after reading the title and summary (12 
studies). 34 studies were selected dealing with the 
Mediterranean diet and its relation to chronic 
diseases. 
III. Results 
III-1. The Mediterranean diet 
MR seems to provide a balanced diet, suitable 
for all  age  groups  and  significantly  reduces  the 
risk of chronic disease [63]. Several studies [64] 
[65] have proven the cardio protective and neuro-
protective roles of MD and its protective roles 
against metabolic disorders, certain cancers, and 
other age-related degenerative diseases. Several 
publications have highlighted the correlation 
between MD and longevity [66] [67]. Sofi et al. 
[68] [69] [70] [71] [72] have shown that greater 
adherence to MD is associated with a significant
Table 1: MDM compounds and their effects on health
The compound Nutrient Mechanism involved Effect on health 
Polyphenol [225] [226] Vegetables and 
fruits, 
Olive oil 
Antioxidant effect, and reduction of 
inflammation 
Protector against type 2 diabetes, 
Protector against cardiovascular disease, 
Reduced risk of lung cancer, 
Flavonoids [226] [227] The fat of the 
seeds 
Antiproliferative Breast cancer prevention 
Phytosterols [225] [228] Soy, Vegetables Reduces serum cholesterol, 
Reduces oxidative stress and 
inflammation 
Risk reduction of cardiovascular 
diseases, Prevention of obesity 
N-3 fatty acids (alpha 
linoleic acid) [225] 
[226] 
Pisces, Flax seed, 




oxidative stress, Reduces 
aggregation of thrombocytes, Anti-
lipidémiant, Antiplatelet, Anti-
inflammatory, Antiarrhythmic 
Stroke prevention, Protector of the 
cardiovascular system, Prevention of 
sudden deaths, Reduced risk of colon 
and rectal cancer, 
Resveratrol [228] [226] The fat of the 
seeds 
 
Reduces aggregation of 
thrombocytes, Reduces serum 
cholesterol 
Protector of the cardiovascular system 
Quercetin [226] Grape seed Vasodilatation, Anti-aggregating 
effect 
Anti-coagulation, Reduced risk of 
hypertension 
Oleic acid [228] [226] Olive oil Inhibits HER2 which plays a role in 
the etiology of metastasis, Protects 
against, atherosclerosis 
Antihypertensive effect, Reduced risk of 
cardiovascular disease, Reduced risk of 
breast cancer 




Antioxidant Reduced risk of lung cancer 
Lutein [225] [253] Green vegetables, 
Grains 
Antioxidant Reduced risk of diabetes, Reduced risk 
of cancer 
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improvement in health status, as evidenced by a 
significant reduction in overall mortality (9). %), 
mortality due to cardiovascular diseases (9%), 6%) 
and the incidence of Parkinson's disease and 
Alzheimer's disease (13%) [69] [70] [71] [72] 
[73]: Several studies have shown that adherence to 
traditional MD is associated with a significant 
reduction in cancer incidence, based on an 
examination of the different components of MD 
[73]. [74] thus benefits of MD related to the 
protective role of phenolic components, reducing 
daily oxidative stress, and the effects of MD in the 
modulation of inflammation [75]. 
III-1-1. Polyunsaturated fatty acids: Omega-3: 
The Mediterranean diet containing several 
nutrients such as fish, which are rich in 
polyunsaturated fatty acids, omega-3, which are 
recommended by American Heart Association 
(AHA) as a cardio-protective [77] especially for 
patients with cardiovascular disease [76]. Thus the 
beneficial effects of fish include the improvement 
of lipid profiles [78] and the reduction of blood 
pressure [79] [80] through the reduction of 
inflammation, oxidation, and coagulation [81] [82]. 
III-1-2. Unsaturated fatty acids (such as olive oil): 
One of the most important aspects of the 
Mediterranean diet is the high concentration of 
unsaturated fatty acids in its fiber and protein 
sources, coupled with a lack of saturated fat [83] 
[84] as well, AHA and the European Society of 
Cardiology (ESC) strongly support the substitution 
of mono- and polyunsaturated fats in place of 
saturated fats and trans-fatty acids [85] [77]. 
Extra virgin olive oil containing potent 
antioxidant properties, including simple and 
complex phenols, which are present in its phenolic 
compounds, mainly include: hydroxytyrosol and 
oleuropein which are potent antioxidants [86]. 
III-1-3. Fruits and vegetables 
The dietary use of fruits and vegetables is 
considered as cornerstone of the Mediterranean 
diet. In fact, the European Society of Cardiology 
encourages the daily consumption of several 
servings of fruits and vegetables [77], the AHA 
strongly recommends the addition of a variety of 
phytochemicals, including fruits and vegetables in 
large quantities [87]. 
III-1-4. Fiber-rich whole grain foods 
Many data suggest beneficial effects of whole 
grains on cardiovascular disease, morbidity and 
mortality, as well as AHA guidelines indicate that 
diets high in fiber, such as whole grains, oats and 
barley, reduce morbidity and mortality related to 
cardiovascular disease lipid-lowering, and 
recommends a total dietary fiber intake of 25 to 30 
g per day [88]. Consumption of whole grains 
increases the consumption of foods high in dietary 
fiber to promote health [77]. 
Randomized control trials show significant 
improvements in CRP levels, cholesterol profile, 
and beneficial effects on body mass index and waist 
circumference in the randomized group consuming 
low calorie whole grains versus those consuming 
grain [89] Thus, observational studies show that the 
benefits go up to the improvement of glucose 
metabolism [90] [91] weight reduction [92], and 
reinforcement of antioxidant capacities [93]. 
III-1-5. Nuts and legumes 
Replacing the consumption of carbohydrates 
and saturated fats with nuts, peanuts, almonds, 
reduces the level of blood fats and the risk of 
cardiovascular disease by 30% to 45% [94] [95] In 
addition, the increased consumption of nuts leads 
to a significant reduction in LDL cholesterol, 
inflammatory proteins and oxidative mediators 
[96] thus soy consumption has beneficial effects 
on endothelial functions [97]. 
III-2. Chronic diseases 
The Mediterranean diet is considered a 
protective factor against many chronic diseases. 
By reducing the important risk factors and 
comorbidities of cardiovascular diseases, such as 
high blood pressure, dyslipidemia and diabetes, 
the cardio-protective effect provided by the 
Mediterranean diet could be an important route for 
the protective effect of the diet. the Mediterranean 
on cognition and dementia [98][99][101][102] 
RM has also been associated with a low risk of 
cardio-metabolic syndrome [100]. 
III-2-1. Cardiovascular diseases 
Adherence to the traditional Mediterranean 
diet has always been beneficial for cardiovascular 
risk. [103] [104] and is considered the most likely 
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dietary model for providing protection against 
coronary heart disease. [105]. A key feature of this 
diet is its low trans fat content. [85] [77]. Extra 
virgin olive oil, the main source of fat in the RM, 
along with plant foods and nuts, makes this dietary 
diet beneficial to health as these fresh foods 
undergo minimal treatment. They are therefore 
rich in fiber, antioxidant polyphenols and essential 
trace elements and macronutrients. Recently, 
primary prevention trials have shown dietary 
intervention to promote adherence to traditional 
DM significantly reducing the risk of 
cardiovascular disease [106]. 
III-2-2. Cognitive Function and Dementia 
The neuroprotective effect can be used to 
improve preventative measures and to critically 
change the way people at high risk of dementia are 
managed. The interactions between nutrition and 
the aging brain are numerous and complex, but 
there are 3 main features that may play a pivotal 
role [107]: Reduced blood flow [108], thought to 
be related to atherosclerosis and arterial plaque 
formation [108]; Mitochondrial dysfunction, 
resulting from the accumulation of reactive 
oxygen species in the brain; and inflammation, 
which is generally considered a natural process of 
aging [109]. A distinct feature of Alzheimar 
Disease is the accumulation of β-amyloid and the 
formation of neurofibrillary tangles composed of 
highly phosphorylated forms of microtubule-
associated tau protein [107], so that β-amyloids 
increase the production of reactive oxygen species, 
which exacerbates the formation of tau 
entanglements as a compensatory mechanism for 
oxidative stress [107]. 
Among other benefits, adherence to MD has 
been associated with a lower risk of various 
chronic diseases [110] [111], and its protective 
properties are seen as a combination of high 
monounsaturated fatty acid consumption and 
polyphenols of olive oil and polyunsaturated fatty 
acids of fish; and antioxidants from fruits, 
vegetables [112]. 
Long-term observational studies show that 
MD as a diet reduces biomarkers of oxidative 
stress and positively affects cognition. Taking 
unsaturated fatty acids (both monounsaturated 
fatty acids and polyunsaturated fatty acids) has 
been associated with improved cognitive 
performance and decreased risk of age-related 
cognitive decline [113]. consumption of 
micronutrients such as vitamins C, E, B12 and 
folate [60] [61] flavonoids [62] and carotenes [61] 
have been associated with a decreased risk of 
cognitive decline and Alzheimar Disease in human 
observational studies. RM could reduce oxidative 
stress [114] and inflammation [115] associated 
with an increased risk of cognitive decline [116] In 
addition, a growing body of evidence, mainly from 
prospective studies, suggests that MD slows down 
the decline age-related cognitive and progression 
of dementia. A meta-analysis, also published in 
2013, assessed the effects of Parkinson's disease 
on stroke, cognitive impairment and depression 
and included a total of 22 studies, including 8 on 
cognitive impairment [119]. High and moderate 
adhesion to the mediterranean diet has been shown 
to be associated with a reduced risk of cognitive 
impairment [119]. 
Despite the fact that the causes of dementia are 
multifactorial, there is growing evidence that 
modifiable risk factors such as cardio-metabolic 
diseases and lifestyle play an important role; Thus, 
nutrition is a key role [120] [121] [117] [118]. The 
typical mechanisms of aging of brain cells show 
signs of atrophy, most of which are related to 3 
main mechanisms, as explained (above) in setting 
up, namely, the decline in supply flow blood and, 
mitochondrial dysfunction (caused by oxidative 
stress), increasing inflammation of the patient's 
brain [107]. There are several mechanisms that 
could explain the positive effects of MD on 
cognitive function. The first is the reduction of 
vascular risk factors and thus improving the blood 
circulation to the brain, so MD adherence favorably 
increases HDL cholesterol and reduces LDL 
cholesterol vascular risk [111] which is strongly 
correlated with cognitive dysfunction [122]. 
Second, MD can protect cognition through its 
effect on oxidative stress. MD is known to be a 
rich source of antioxidants such as vitamin E, 
vitamin C, folate, and polyphenols [123]. 
Epidemiological studies suggest that vitamin E is 
used for protection against cognitive disorders 
[124] and nutrients, such as folate [125]. Third, the 
effect MD on cognitive function can be mediated 
by the lowering of inflammation in the brain. MD 
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with the ability to reduce inflammatory 
biomarkers such as C-reactive protein (CRP) in 
neuritic plaques and nfts in the brain and serum 
[126] [127]. Thus diet, such as fruits, vegetables, 
cereals, and unsaturated fatty acids in the 
Mediterranean diet, is associated with a lower 
risk of cognitive decline [128] [129]. 
III-2-3. Type 2 diabetes 
Diabetes prevention studies focusing on 
lifestyle [136] have shown strong reductions in 
the risk of type 2 diabetes [137] [138] in favor 
of this beneficial effect, the American Diabetes 
Association recommends that patients with 
newly diagnosed type 2 diabetes are being 
treated with lifestyle-related pharmacotherapy 
[139] and also recommends low-carbohydrate or 
low-fat diets for weight loss in overweight or 
obesity associated with type 2 diabetes [140] 
because drug therapy alone often fails over time 
[141], and some drugs are at risk for 
cardiovascular disease and other serious 
complications [142] [143]. For these reasons, 
the combination of pharmacotherapy and 
lifestyle changes is proving to be the most 
effective. 
Regarding lifestyle, taking the example of the 
Mediterranean diet characterized by its low 
carbohydrate content and high proportion of 
monounsaturated fatty acids provide 
cardiovascular benefits and increase insulin 
sensitivity [144] [145] in addition to changes in 
fashion of life promote weight loss and increase 
activity levels, which facilitates the management 
of diabetes [139]. A study published by United 
Kingdom Prospective Diabetes Study (UKPDS) 
evaluating the effect of the Mediterranean diet on 
body weight in 190 overweight women who were 
followed for 2 years in a Mediterranean diet, lost 
weight in a significant way [146 ] also 
prospective studies have shown that 
Mediterranean dietary habits are associated with 
reduced risk of type 2 diabetes, in healthy 
participants [147]. Trials have shown that 
Mediterranean diets protect against insulin 
resistance and metabolic syndrome, thus, a 
mechanism through which Mediterranean diets 
can improve glycemic control may be through 
improved insulin sensitivity mediated increased 
levels of circulating adiponectin [144] [148] [174]. 
III-2-4. The arterial pressure 
According to the medical diagnosis based on 
the guidelines of the National Mixed Committee 
[152] hypertension is defined as an increase in 
blood pressure; systolic beyond 140 mmHg or 
diastolic blood pressure greater than 90 mmHg 
[152]. High blood pressure is a major risk factor 
for cardiovascular disease and is independent of 
other factors [31]. Therefore, from the point of 
view of public health, it is urgent to find ways to 
fight this disease. 
The Mediterranean diet is of the utmost 
importance in the prevention and treatment of 
hypertension [149] and the reduction of its 
complications such as cardiovascular disease and 
stroke. In fact, several publications reporting 
results of clinical studies that confirm the 
protective role of the Mediterranean diet vis-à-vis 
systolic blood pressure both systolic and diastolic 
[150]. Thus a study by Beitz R, et al. showed a 
systolic blood pressure drop of 3.0 mmHg in 
women who consumed a high amount of fruit, 
vegetables or vitamin C [153]. also, a prospective 
cohort study has shown that consumption of fruits 
and vegetables is inversely associated with blood 
pressure in the population of the Mediterranean 
basin with a high intake of vegetable fats [154]. 
III-2-5. Obesity 
Obesity predisposes to a number of conditions, 
including cardiovascular diseases [155] [156], type 
2 diabetes [157] [158], metabolic syndrome [159], 
non-alcoholic fatty liver disease [160], certain 
types of cancer [161] [162], obstructive sleep 
apnea [163], osteoarthritis [164] and asthma [165] 
and increases the risk of premature death [166], 
resulting in health costs raised all over the world 
[23]. Factors predisposing to obesity include 
excessive food intake, lack of physical activity, 
and genetic susceptibility [167]. However, obesity 
is a heterogeneous condition and thus intra-
abdominal adipose tissue accumulation has a 
greater impact on the development of cardio-
metabolic risk factors and significant lipid profile 
effects [168]. The increased availability of free 
fatty acids, the release of pro-inflammatory 
cytokines and adipokines from adipose tissue, 
hepatic insulin resistance, inflammation, and the 
resulting dyslipidemia are among the many 
metabolic disorders associated with this affection, 
Benyaich (2017)  
 
J. Appl. Adv. Res.   ●   Vol. 2   Issue 6  339 
 
also hormonal status and drug treatments may also 
play an important role [169]. Low-calorie diet is 
still the main and essential step in the treatment of 
obesity, associated with increased physical activity 
and lifestyle changes [170]. 
RM is the most common tool for weight 
reduction in obese individuals [171]. Even 
moderate weight loss of about 10% or less has 
been shown to contribute to several health benefits 
including improved metabolic parameters, reduced 
blood pressure, and increased longevity [172] 
[173]. evidence that calorie restriction improves 
insulin sensitivity and reduces systemic 
inflammation [174] [175]. Several studies have 
shown the benefits of the Mediterranean diet for 
weight loss in obese patients, by evaluating 
physical and biochemical markers after at least 6 
months after adherence to theMD[176] [177] 
[178]. Mediterranean diet has been shown to be 
associated with greater improvement in insulin 
sensitivity parameters [176]. 
Adipose tissue is an endocrine organ with a 
large and biologically active secretome [180] 
[181] and fat tissue in obese individuals is 
characterized by increased expression and / or 
secretion of several pro-inflammatory cytokines. 
as well as adipokine to promote inflammation, 
atherogenesis and insulin resistance, while the 
biosynthesis of anti-inflammatory, anti-
atherogenic and insulin-sensitizing adipokines 
such as adiponectin decreases [182] [183] Several 
studies have shown an increase in circulating 
levels of leptin and an increase in adiposity 
associated with leptin resistance and that this 
condition may contribute to the onset and / or 
maintenance of obesity [184]. ] [185] 
One study shows decreased circulating levels of 
Epidermal Growth Factor (EGF) after introduction 
of the Mediterranean diet in obese subjects in 
parallel with an improvement in insulin sensitivity. 
[190]. During fasting, salivary and plasma EGF 
increases physiologically [191] to inhibit gastric 
acid secretion and preserve the esophageal and 
gastrointestinal system (as a sign of intestinal 
adaptation to food). Increased EGF may result in 
insulin-like biological activities in tissues 
expressing high numbers of EGFR receptors 
(EGFR), such as fat and skeletal muscle [192]. By 
binding to EGFR, a receptor belonging to the 
family of tyrosine kinase receptors, such as the 
insulin receptor [201], EGF can amplify 
downstream signaling of insulin by PI3-kinase 
recruitment. additional, leading to EGF-induced 
translocation of GLUT4 on plasma membranes 
and stimulation of glucose uptake into target 
tissues [192]. These molecular mechanisms are 
important in insulin resistance states, including 
obesity, in which the increase in EGF due to 
dietary restriction can trigger insulin-like 
compensatory mechanisms, so insulin regulates 
expression of EGF [193]. This explains the 
parallel decrease in insulin and EGF in patients 
with more constant weight loss, in which insulin 
sensitivity has been improved or restored [193]. 
Lactate Dehydrogenase (LDH) is an 
intracellular enzyme that is released into the 
bloodstream when tissues are destroyed or injured. 
Therefore, LDH is an important clinical marker of 
tissue or cell integrity. In obese patients, adipose 
tissue is dysfunctional [194] [195] has a reduced 
ability to store and retain non-esterified fatty acids 
(NEFA), resulting in increased circulating levels 
of AGNE, thereby promoting the development of 
lipotoxicity in peripheral tissues [196]. 
III-2-6. Cancer 
Tobacco control, reduction of excessive 
alcohol consumption, vaccination against human 
papillomavirus and reduced exposure to ultraviolet 
light are obvious strategies for reducing cancer 
incidence rates [197] [198]. As citing the World 
Cancer Research Fund (WCRF) such examples; 
Aflatoxins with liver cancer, red meat and / or 
processed meat with colorectal cancer, alcohol 
with cancers of the gastrointestinal tract, and, for 
smokers, β-carotene increases the risk of lung 
cancer [199] [200]. 
Guidelines proposed by WCRF and 
recommendations on nutrition and physical 
activity for cancer prevention [202] [203]. have 
been consistent with those aimed at preventing 
other chronic diseases, such as diabetes and heart 
disease [203] [204] [205], which raises the 
prospect of a huge public health problem and, 
therefore, medical care. [204] [205]. Both the 
aging of the population and changes in the 
distribution of risk factors contribute to the 
increased burden of cancer [25] [26] nutrition and 
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physical activity are also among the most 
important determinants cancer risk in humans, 
through their contributions to obesity, which is a 
risk factor for many malignancies [199] [206]. 
III-2-7. Oxidative stress 
MR reduces oxidative stress [114] and C-
reactive protein and interleukins involved in the 
mechanisms of oxidative stress leading to chronic 
pathophysiology [132] [133]. The neuroprotective 
effects of the Mediterranean diet are related to its 
ability to reduce inflammation and oxidative 
stress, which are also related to the 
pathophysiology of degenerative diseases [134] 
[135] adherence to RM, with higher consumption 
of fruit and vegetable rich in phytochemicals, 
demonstrates an increase in endogenous and 
exogenous antioxidant levels, enhancing immunity 
and protecting the selected sample against 
oxidative stress and maintaining a healthy state. 
Thus vegetable consumption has been closely 
associated with a low risk of degenerative diseases 
[241] [242]. Eating habits can play a key role in 
regulating the redox state of human plasma 
improving defense against oxidation. [245] [246, 
247, 249]. The Mediterranean diet is associated 
with a significant reduction in several risk factors, 
including cardiovascular risk [250, 251, 252]. 
III-2-8. Cholesterol and oxidative stress 
The bioavailable quantity of bioactive molecules 
in subjects with high consumption of fruits and 
vegetables promotes their protective and preventive 
action against lipid oxidation and therefore against 
oxidative stress [233]. Also, the influence of the rate 
Plasma cholesterol on the atherosclerotic process and 
the effects of diet-induced cholesterol influence the 
progression and development of cardiovascular 
disease [235]. Several researchers have also 
suggested that diets have a significant effect on the 
mechanisms of progression of atherosclerosis and 
thrombosis [236, 237]. 
Numerous studies have demonstrated the 
inhibitory activity of several compounds present in 
fruits and vegetables on the oxidation of LDL in 
vitro [238, 239]. Thus, interesting results seem to 
highlight the circulating levels of carotenoids 
(lutein, zeaxanthin, cryptoxanthin, lycopene, a and 
b-carotene), vitamin A and vitamin E have reached 
the highest values in subjects with a higher great 
adherence to the Mediterranean diet [238, 239]. 
Several studies show that vitamin A reduces the 
production of pro-inflammatory cytokines such as 
TNF-a and IL-12 and promotes the activation of 
lymphocyte subpopulations through the secretion 
of specific cytokines (eg IL-10). , [240], thus the 
phytochemical components of fruits and 
vegetables consist of different phytochemicals 
beneficial to the systemic circulation, thus 
absorbed antioxidants reach the large intestine and 
contribute to the protection against gastrointestinal 
diseases induced by oxidation [243, 244]. 
III-2-9. Dietary recommendations 
The guidelines and recommendations 
published in several reports to maintain body 
weight within the normal range [199, 218]. The 
equivalent of 60 minutes of exercise per day to be 
physically active; consume a plant-based diet 
comprising a variety of fruits and vegetables; 
choose unprocessed cereals and grains over 
processed products; limit the intake of red meat 
and salt; avoid or limit alcohol consumption, to 
meet nutritional needs without the use of food 
supplements [218] avoid energy-rich foods, sugary 
drinks, fast foods and processed meat, and 
genetically modified foods modified to increase 
certain types of cancer (such as colorectal cancer) 
by modification in the nucleic acids thus causing 
changes in enzymatic activity [219, 220, 223, 224]. 
IV. Discussion 
Adopting a healthy lifestyle is the cornerstone of 
chronic disease prevention and treatment, and 
healthy eating is a major lifestyle change. Various 
studies show that dietary treatment is most effective 
for reducing the average body weight of people 
suffering from overweight or obesity, and a 
statistically significant reduction in BMI, and thus 
showing beneficial effects on health [172, 173, 179]. 
The traditional MD is a plant-based diet, 
where vegetables, fruits, cereals (preferably whole 
grains), legumes and nuts, fish and shellfish, white 
meat is consumed in large quantities and 
frequently. The main source of dietary fat in MD 
is olive oil and adequate daily water intake must 
be ensured. The Mediterranean diet also includes a 
moderate consumption of eggs and dairy products, 
Benyaich (2017)  
 
J. Appl. Adv. Res.   ●   Vol. 2   Issue 6  341 
 
on the contrary, the consumption of red meats, 
processed meats and foods rich in sugars and fats 
is reduced in quantity and frequency. Seasonality, 
biodiversity, the use of traditional and local food 
products are also important elements of this trend. 
In addition, the Mediterranean diet also includes 
qualitative cultural and living elements, such as 
conviviality, culinary activities, physical activity 
and adequate rest [40]. Thus MD is known as one 
of the healthiest diets [39]. 
The critical importance of food and nutrition 
in cancer prevention is widely recognized, due to 
an impressive amount of data from 
epidemiological, clinical and laboratory research 
[199]. So, the issues of diet and cancer and the 
problems of diet, nutrition and cancer come from 
different types of research, including animal and 
mechanical studies, ecological studies in humans 
(correlation studies at the level of population, 
useful for generating hypotheses), observational 
analytical epidemiology studies (ie, case-control 
and cohort studies) and dietary intervention trials. 
In laboratory studies using cell cultures and 
experimental animal models, nutrients and other 
bioactive food components have been shown to 
affect key biological processes involved in the 
regulation of cell growth and carcinogenesis. 
Foods are naturally complex and provide many 
bioactive substances that can act individually and / 
or synergistically to influence processes such as 
cell differentiation and apoptosis, as well as the 
hormonal regulation of cellular functions. 
Hypocaloric diet is still the main and essential step 
in the treatment of obesity, associated with 
increased physical activity and lifestyle changes 
[170] Also, the dose-response relationship: For 
example, squamous cell carcinoma of the 
esophagus is very different from esophageal 
adenocarcinoma: the former is more strongly 
related to smoking and alcohol consumption in 
Western populations [207] [208], or human 
papillomavirus (HPV) infection in other 
populations, such as those in China [209] [210]; 
the latter is more closely associated with obesity 
and / or reflux disease [211]. In addition, the 
dietary factors associated with these two cancers 
have some overlap, but are also quite distinct 
[212] [213]. Similarly, an analysis of the NIH-
AARP study on diet and health [214] pointed out 
that the high risk of endometrial cancer in obese 
compared to non-obese women was higher for 
subtypes. Type I tumors (endometrioid). With 
respect to nutrients, increased consumption of 
phytoestrogens was associated with a reduced risk 
of mucinous ovarian cancer, but no other subtypes 
of ovarian cancer, in the Australian ovarian cancer 
[215]. For example, in the large-scale long-term 
pooling of prospective studies on diet and cancer 
[212, 213], a protective effect of fruit and 
vegetable consumption on esophageal breast 
cancer (ER) Negative but not breast cancer has 
been consistently demonstrated in 20 studies [216, 
217]. Several factors and their interactions, namely 
tobacco, dietary protein, and alcohol [221] 
increase the risk of cancer of various types of 
cancer [221] and exposures experienced by a 
person during his life including: metabolism, 
hormones, body composition, physical activity, 
gut microbiome, inflammation, oxidative stress, 
aging, diet, and alcohol, and broader psychosocial 
and environmental [222]. 
Bacteria can either promote or suppress cell 
growth and metastasis through bacterial toxins 
induced by the secretion of bacterial proteins 
leading to changes in gene expression, altering the 
tumor (inflammation, immune functions , or by 
altering host metabolism [229], and by promoting 
the production of endogenous factors that cause 
carcinogenesis (such as bile acids and steroid 
hormones) [230], and since diet influences both 
the type and the number of intestinal 
microorganisms [230] [231] the microbiome in the 
development of cancer, including host genome 
interactions with microbiota [232]. Thus, one of 
the main intermediate step in the the link between 
diet and cancer remain in research, and require 
technologies in the prevention and development of 
cancer to provide u ideas and data relevant to the 
relationship between food intake and cancer risk 
and progression. 
The total antioxidant capacity of biological 
samples can also be evaluated in clinical studies 
that measure the end products of degradation of 
endogenous compounds such as lipids or DNA. 
Changes from baseline levels of these products 
could then be attributed to changes in the 
antioxidant capacity of the diet, so the antioxidant 
capacity of the biological samples can be 
controlled by a variety of tests, which do not 
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necessarily reflect the physiological mechanisms 
in humans vivo [248]. 
Several studies describe insulin and leptin 
resistance in obese subjects. The relationships 
between these two hormones are complex and 
poorly understood, and there is evidence that they 
are associated with body fat through different 
mechanisms [186, 187]. Other studies with 
comparable or even larger samples had similar 
results and found a statistically significant 
decrease in leptin levels and not adiponectin in 
weight loss [188] [189]. Several nutrients 
characterize MD and protect against various 
chronic diseases, such as olive oil, and prospective 
studies have shown that olive oil significantly 
improves cognitive function [130, 131]. 
V. Conclusion 
The traditional Mediterranean diet has a 
protective effect against cardiovascular diseases, 
oxidative stress, dyslipidemia, diabetes mellitus, 
blood pressure, cancer, neurodegenerative diseases 
and obesity, this protective effect of the 
Mediterranean diet is provided by antioxidants, 
anti-inflammatories and bioactive components of 
foods characteristic of the Mediterranean basin, 
reducing the risk of development of chronic 
diseases. 
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